C-X-C Motif Chemokine Ligand 16 Is a Potent Predictor of Outcomes in Dialysis Patients

被引:1
|
作者
Liu, Wenjin [1 ]
Wang, Lulu [2 ]
Li, Xiurong [3 ]
Gao, Chaoqing [4 ]
Zhou, Jianmei [4 ]
Zhou, Jiajun [4 ]
Wang, Liang [5 ]
Sun, Zhuxing [5 ]
Chu, Hong [6 ]
Fan, Wei [6 ]
Bai, Youwei [7 ]
Yang, Junwei [2 ]
机构
[1] Univ Utah Hlth Sci, Dept Internal Med, Div Nephrol & Hypertens, Salt Lake City, UT USA
[2] Nanjing Med Univ, Ctr Kidney Dis, Affiliated Hosp 2, Nanjing, Peoples R China
[3] Soochow Univ, Dept Nephrol, Affiliated Hosp 3, Changzhou, Peoples R China
[4] Wannan Med Coll, Dept Hemodialysis, Yijishan Hosp, Wuhu, Peoples R China
[5] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Nephrol, Wuxi, Jiangsu, Peoples R China
[6] Jiangsu Univ, Affiliated Yixing Peoples Hosp, Dept Nephrol, Yixing, Peoples R China
[7] Luan Peoples Hosp, Dept Nephrol, Luan, Peoples R China
关键词
C-X-C motif chemokine ligand; Dialysis; Inflammation; Biomarker; Kidney disease; REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; KIDNEY-FUNCTION; SOLUBLE CXCL16; MORTALITY; HEMODIALYSIS; INFLAMMATION; RISK; ATHEROSCLEROSIS; CARDIOMYOPATHY;
D O I
10.1159/000518400
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: C-X-C motif chemokine ligand 16 (CXCL16) is an inflammatory marker that has been found to be predictive of outcomes in patients with cardiovascular disease. Our previous work has also demonstrated its relation to cardiac injury in dialysis patients. However, it is yet unclear whether there is an association between CXCL16 and adverse outcomes in dialysis patients. We aimed to evaluate its prognostic value along with several traditional inflammatory markers in the current study. Methods: This is a multicenter longitudinal study of prevalent dialysis patients. Circulating inflammatory markers including CXCL16, C-reactive protein (CRP), tumor necrosis factor-alpha, and interleukin-6 (IL-6) were measured using a multiplex assay. The primary outcomes were all-cause mortality and a composite of major adverse cardiovascular events (MACEs). The associations between biomarkers and outcomes were analyzed using Cox proportional hazards regression models. Results: Of the 366 participants with available plasma samples, the average age was 52.5 (+/- 12.1) years, and there were 160 (43.7%) female participants. For all-cause mortality, logarithmically transformed CXCL16, IL-6, and CRP were independent predictors after adjustment for covariates. When the 3 markers were included in the same model, CXCL16 was the only one remaining its significance. For MACEs, logarithmically transformed CXCL16 and IL-6 were significant predictors when analyzed separately and CXCL16 was an independent predictor even after adjustment for IL-6. When the biomarkers were analyzed as categorical variables, only CXCL16 was associated with both outcomes. Adding CXCL16 to established risk factors improved risk prediction as revealed by Net Reclassification Index (NRI). Conclusion: Using a multimarker approach, we determined that CXCL16 is a potent predictor of all-cause mortality and cardiovascular events in dialysis patients. Our data suggest CXCL16 may improve risk stratification and could be a potential interventional target.
引用
收藏
页码:725 / 734
页数:10
相关论文
共 50 条
  • [1] High Levels of Circulating Chemokine (C-X-C motif) Ligand 11 Are Associated with Euthyroid or Subclinically Hypothyroid Autoimmune Thyroiditis and with Chemokine (C-X-C Motif) Ligand 10
    Antonelli, Alessandro
    Ferri, Clodoveo
    Ferrari, Silvia Martina
    Frascerra, Silvia
    Ruffilli, Ilaria
    Caponi, Laura
    Ulisse, Salvatore
    Miccoli, Mario
    Miccoli, Paolo
    Fallahi, Poupak
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2012, 32 (02): : 74 - 80
  • [2] C-X-C Motif Chemokine 10 and Chemokine (C-X-C Motif) Receptor 3 are Elevated in Synovial Fluid of Psoriatic Arthritis Patients
    Muntyanu, Anastasiya
    Abji, Fatima
    Liang, Kun
    Pollock, Remy
    Chandran, Vinod
    Gladman, Dafna
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1237 - 1238
  • [3] Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases
    Antonelli, Alessandro
    Ferrari, Silvia Martina
    Giuggioli, Dilia
    Ferrannini, Ele
    Ferri, Clodoveo
    Fallahi, Poupak
    AUTOIMMUNITY REVIEWS, 2014, 13 (03) : 272 - 280
  • [4] Soluble C-X-C chemokine ligand 16 levels are increased in gout patients
    Gong, Qi
    Wu, Fan
    Pan, Xuebo
    Yu, Jiawen
    Li, Yilan
    Lu, Tingting
    Li, Xiaokun
    Lin, Zhuofeng
    CLINICAL BIOCHEMISTRY, 2012, 45 (16-17) : 1368 - 1373
  • [5] The Role of Autophagy and the Chemokine (C-X-C Motif) Ligand 16 During Acute Lung Injury in Mice
    Gao, Ye
    Wang, Ni
    Li, Rui H.
    Xiao, Yang Z.
    MEDICAL SCIENCE MONITOR, 2018, 24 : 2404 - 2412
  • [6] Diagnostic and prognostic values of C-X-C motif chemokine ligand 3 in patients with colon cancer
    Ruan, Guo-Tian
    Gong, Yi-Zhen
    Liao, Xi-Wen
    Wang, Shuai
    Huang, Wei
    Wang, Xiang-Kun
    Zhu, Guang-Zhi
    Liao, Cun
    Gao, Feng
    ONCOLOGY REPORTS, 2019, 42 (05) : 1996 - 2008
  • [7] The dual roles of C-X-C MOTIF chemokine LIGAND 10 in pediatric osteosarcoma
    Chen, Xiang
    Clement, Margaret
    Hicks, John
    Man, Tsz Kwong
    CANCER RESEARCH, 2022, 82 (12)
  • [8] Chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) receptor 2 autocrine loop contributes to cellular proliferation, migration and apoptosis in cervical cancer
    Sun, Jiping
    Yuan, Jianrong
    BIOENGINEERED, 2022, 13 (03) : 7579 - 7591
  • [9] Role and clinicopathologic significance of CXC chemokine ligand 16 and chemokine (C-X-C motif) receptor 6 expression in gastric carcinomas
    Xing, Ya-nan
    Xu, Xiao-yan
    Nie, Xiao-cui
    Yang, Xue
    Yu, Miao
    Xu, Hui-mian
    Liu, Yun-peng
    Takano, Yasuo
    Zheng, Hua-chuan
    HUMAN PATHOLOGY, 2012, 43 (12) : 2299 - 2307
  • [10] Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease
    Lee, Yu Ho
    Kim, Ki Pyo
    Park, Sun-Hwa
    Kim, Dong-Jin
    Kim, Yang-Gyun
    Moon, Ju-Young
    Jung, Su-Woong
    Kim, Jin Sug
    Jeong, Kyung-Hwan
    Lee, So-Young
    Yang, Dong-Ho
    Lim, Sung-Jig
    Woo, Jeong-Taek
    Rhee, Sang Youl
    Chon, Suk
    Choi, Hoon-Young
    Park, Hyeong-Cheon
    Jo, Young-Il
    Yi, Joo-Hark
    Han, Sang-Woong
    Lee, Sang-Ho
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (02) : 295 - 305